Vascular disease in the brain may dictate the onset of dementia in the elderly, according to a study published in the September issue of Radiology.
Vascular disease in the brain may dictate the onset of dementia in the elderly, according to a study published in the September issue of Radiology.
Debate on the association between dementia and cerebrovascular disease is as old as imaging itself. But even though the causes of dementia are multiple - and many remain unknown - some imagers point at cerebrovascular disease as one of the most relevant.
Radiologist Dr. Aart Spilt and colleagues at the University Medical Center of Leiden in the Netherlands explored the connection between structural brain damage and total cerebral blood flow. They prospectively enrolled 17 elderly patients with late-onset dementia, 16 subjects of the same age with normal cognitive function, and 15 young healthy controls.
Using MRI, they found that demented elderly individuals showed significantly more structural brain damage and lower cerebral blood flow than normal subjects, even among the elderly.
"Clinicians should be aware that hypotension - as well as hypertension - needs to be prevented to diminish the periods with low cerebral blood flow," Spilt said.
Elderly patients with dementia showed significantly higher scores for number and extent of white matter areas with signal hyperintensity and lower magnetization ratios than healthy subjects of similar age. Patients with dementia also showed a cerebral blood flow that was 108 mL/min lower than normal elderly subjects. The difference was also statistically significant.
The imaging protocol included:
Although uncooperative patients posed a challenge, MRI allowed researchers to monitor both structural and functional changes in these patients. Blood flow and structural brain damage were easily seen on T2-weighted MR images, Spilt said.
Researchers know that patients presenting with Alzheimer's and other forms of dementia accumulate amyloid plaque in the brains. But the type of gene mutation causing it affects less than 5% of these patients.
Many elderly patients who are dementia-free, on the other hand, also present with amyloid plaque deposits in their brains. Researchers need to further investigate the relationship between dementia and cerebrovascular disease as a separate cause, Spilt said.
For more information from the Diagnostic Imaging archives:
Amyloid plaques hasten progress of dementia
MR finds widespread clinical use in MS diagnosis, management
Imagers seek answers for Alzheimer's diagnosis
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.